Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
06/2010
06/17/2010US20100150945 Anti-mdl-1 antibodies
06/17/2010US20100150943 Immunogenic compositions for gram positive bacteria
06/17/2010US20100150940 Anti-igf antibodies
06/17/2010US20100150939 Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
06/17/2010US20100150937 Antagonists of pcsk9
06/17/2010US20100150926 Fusion protein capable of binding vegf-a and tnf-alpha
06/17/2010US20100150923 Fusion proteins of recombinant sars coronavirus structural proteins, their production and uses
06/17/2010US20100150909 PTHrP-DERIVED MODULATORS OF SMOOTH MUSCLE PROLIFERATION
06/17/2010US20100150908 Affinity matured CRIg variants
06/17/2010US20100150904 Binding members for ige molecules
06/17/2010US20100150902 Anti-cd151 antibodies and their use in the treatment of cancer
06/17/2010US20100150901 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor
06/16/2010EP2196541A1 Anti-glypican-3 antibody having improved kinetics in plasma
06/16/2010EP2196540A2 Combinatorial DNA library for producing modified N-Glycans in lower eukaryotes
06/16/2010EP2196536A1 Methods for production of proteins
06/16/2010EP2195339A2 A process for producing hepcidin
06/16/2010EP1622921B1 Variants of beta-glucosidases
06/16/2010CN1875029B Expression in filamentous fungi of protease inhibitors and variants thereof
06/16/2010CN1526732B Process for producing high pureness albumin solution
06/16/2010CN1500095B Polymer conjugates of neublastin and methods of using ssame
06/16/2010CN1487996B Transgenic transchromosomal rodents for making human antibodies
06/16/2010CN101743256A an anti-cancer cytotoxic monoclonal antibody
06/16/2010CN101736068A Method for preparing yeast amino acid by using pichiapastoris
06/16/2010CN101736067A Lactoalbumin antihypertensive peptide, preparation method and application thereof
06/16/2010CN101736066A Method for producing no-fishy smell scale collagen peptide by utilizing macroporous absorbent resin
06/16/2010CN101736065A Method for preparing polypeptide by beer sediment
06/16/2010CN101736064A Process for preparing immune reinforcement peptide for enzymolysis on ocean shell and application thereof
06/16/2010CN101736063A Scale production process for recombinant human insulin
06/16/2010CN101736062A Method for preparing recombinant porcine alpha interferon standard substance
06/16/2010CN101735310A Human papilloma virus (HPV) fusion protein, gene, carrier, strain, preparation method and application
06/15/2010US7737262 For primates; p42 nucleic acid encoding a p42 polypeptide from the C-terminal processing fragment of Plasmodium falciparum major merozoite surface protein gp195 which hybridizes under high stringency conditions
06/15/2010US7737117 Insecticidal protein which enhance insect resistance in plants; biological pest control;
06/15/2010US7737116 Modified and stabilized GDF propeptides and uses thereof
06/15/2010US7736899 Cells and method for producing proteins comprising an unconventional amino acid
06/15/2010US7736878 Recombinant forms of DNA sequences for a cyclobutane pyrimidine dimer (CPD) glycosylase protein, that are capable of expression at high level, used in topical formulations for treatment of photosensitive or autoimmune disease that are exacerbated by DNA damage from UV light exposure, such as lupus
06/15/2010US7736876 Peptide-forming enzyme gene
06/15/2010US7736873 An isolated nucleic acid molecule comprising a nucleotide sequence which encodes the polypeptide comprising the outer membrane protein antigens of gramnegative bacteria, which can be used to prevent and treat gramnegative bacteria infection in mammals, such as humans; immunology; vaccines
06/15/2010US7736872 cells comprising a translation system comprising an synthetase enzymes encoded by a nucleotide sequence and the complementary polynucleotide sequence; protein biosynthesis
06/15/2010US7736871 Nucleotide sequences coding dipeptide forming enzyme
06/15/2010US7736870 Nucleic acid sequences having gene transcription regulatory qualities
06/15/2010US7736869 nucleotide or DNA constructs comprising expression cassettes comprising promoters operably linked to transgene open reading frames, used in protein production, diagnostics, transgenic plants and animals and the therapeutic field
06/15/2010US7736868 Nucleic acid sequences having gene transcription regulatory qualities
06/15/2010US7736867 Nucleic acids encoding polypeptide inhibitors of human plasmin derived from the Kunitz domains
06/15/2010US7736859 incubating a sample from humans with monoclonal antibodies or fragments, that specifically binds epitopes of campylobacter antigens, then detecting the formation of antigen-antibody complexes which is indicative of an infection of campylobacter
06/15/2010US7736652 Comprises immunoglobulin-immunostimulant fusion protein for use in preventing and treating infections, cancer and autoimmune disorders; genetic vaccination; gene therapy
06/15/2010US7736650 recombinant expression vectors and plasmids comprising restriction sites for cloning antibodies
06/15/2010US7736649 preventing the viral entry process into target cells, by inhibiting the binding of viral surface glycoprotein to cell surface CD4, to fusion coreceptors CCR5 chemokine receptors and the transient conformation fusion intermediate that ultimately folds into a conformation capable of mediating fusion
06/15/2010US7736648 Anti-RSV G protein antibodies
06/15/2010US7736644 Monoclonal antibody for use as tool in treatment and prevention of cell proliferative disorders; immunotherapy; tissue targeted therapy
06/15/2010US7736642 Yeast-based vaccine for inducing an immune response
06/15/2010US7736638 Interleukin-15 antagonist peptide
06/15/2010CA2319658C Continuous fermentation process
06/15/2010CA2294472C Torsin, torsin genes, and methods of use
06/15/2010CA2286323C Cell culture media for enhanced protein production
06/15/2010CA2250080C Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications
06/10/2010WO2010065818A1 Chimeric immunoreceptor useful in treating human cancers
06/10/2010WO2010065594A2 Cells for increased protein expression comprising one or more release factors and methods of use
06/10/2010WO2010065044A1 Blocking mesothelin peptide fragments
06/10/2010WO2010064454A1 Method for producing antibody directed against protein expressed on cell surface
06/10/2010WO2010064262A2 A process for production of water soluble melanin using a strain of the fungus gliocephalotrichum
06/10/2010WO2010064232A2 USES OF GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS
06/10/2010WO2010020777A3 Protein expression
06/10/2010US20100146668 Insect-resistant protein and insect-resistance gene encoding the insect-resistant protein
06/10/2010US20100146661 Sugar beet genes involved in stress tolerance
06/10/2010US20100146650 Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses
06/10/2010US20100146647 Antibody producing non-human mammals
06/10/2010US20100145032 Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof
06/10/2010US20100145031 Methods for producing antibodies from plasma cells
06/10/2010US20100145028 Increasing The Production Of Recombinant Antibodies In Mammalian Cells By Site-Directed Mutagenesis
06/10/2010US20100145024 Long wavelength engineered fluorescent proteins
06/10/2010US20100145016 Compositions and methods for purifying calreticulin
06/10/2010US20100145015 Compositions and methods for increasing immunogenicity of glycoprotein vaccines
06/10/2010US20100144837 Diagnosis and treatment of malignant neoplasms
06/10/2010US20100144640 Molecules designated b7l-1
06/10/2010US20100144637 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
06/10/2010US20100144633 Chloroplast expression of membrane proteins
06/10/2010US20100144632 Administering a polypeptide having at least one of anti-angiogenic, tumor-suppressive, or anti-migratory activity, but does not have stimulation of cell proliferation activity
06/10/2010US20100144604 Novel cellular factor-containing solution compositions
06/10/2010US20100143973 Interleukin-11 Fusion Proteins
06/10/2010US20100143972 Method of Making Cyclic Polypeptides with Inteins
06/10/2010US20100143971 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
06/10/2010US20100143970 Transglutaminase having disulfide bond introduced therein
06/10/2010US20100143969 Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms
06/10/2010US20100143943 Detection of dysplastic or neoplastic cells using anti-mcm2 antibodies
06/10/2010US20100143936 Novel Specific Arabinose Transporter from the Yeast Pichia Stipitis, and Uses Thereof
06/10/2010US20100143912 Specific n-terminal labeling of peptides and proteins in complex mixtures
06/10/2010US20100143433 Bone morphogenetic proteins containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof
06/10/2010US20100143415 Streptococcus Pneumoniae Antigens
06/10/2010US20100143412 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
06/10/2010US20100143402 Intergenic sites between conserved genes in the genome of modified vaccinia ankara (mva) vaccinia virus
06/10/2010US20100143395 Material with immunogenicity
06/10/2010US20100143390 Polypeptides for inducing a protective immune response against staphylococcus epidermidis
06/10/2010US20100143376 Antibodies Specific for Rubella Virus
06/10/2010US20100143367 Novel anti-cd98 antibody
06/10/2010US20100143360 Human vascular endothelial growth factor 2
06/10/2010US20100143342 Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies
06/10/2010US20100143338 Treatment of t-cell mediated diseases
06/10/2010US20100143316 Novel strain of bacillus amyloliquefaciens and its use
06/10/2010US20100143315 Method for Improving the Specific Effector Function of Single-Chain Antigen-Recognizing Genetic Constructs (SCARC) Through Murinization Thereof
06/10/2010CA2745798A1 Blocking mesothelin peptide fragments
1 ... 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 ... 1125